arrow
R

Rebecca C. Brady

university of maryland baltimore
H指数:30
被引数:3,906

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost

用于COVID-19基础免疫的疫苗平台决定了人体B细胞对疫苗加强针的反应质量。

2026-02-250
PRE
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

使用双价信使核糖核酸严重急性呼吸综合征冠状病毒2疫苗加强接种后的黏膜和系统性抗体应答

2025-04-290
PRE
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants
2024-02-097
OA
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial

不同启动方案后延迟异源禽流感a (H7N9) 疫苗加强的安全性和免疫原性: 一项随机临床试验

2023-07-193
OA
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
2023-07-1117
OAAI
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults

健康成人甲型H1N1流感pdm09多中心对照人类感染研究

2023-01-265
OA
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
2022-07-01126
OAAI
Homologous and Heterologous Covid-19 Booster Vaccinations
2022-03-17399
OAAI
Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination

用流感病毒H5血凝素抗原引发疫苗接种可显着增加异源H5加强疫苗接种诱导的T细胞反应的持续时间

2016-07-207
OAAI
Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor

单剂量口服霍乱活疫苗CVD 103-HgR可预防霍乱弧菌O1 El Tor的人类实验性感染

2016-03-21147
OAAI
A Randomized Trial of Progesterone in Women with Recurrent Miscarriages
2015-11-26207
OAAI
Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine

单次低剂量或高剂量的2型流感 (H5N1) 灭活疫苗在先前用1型流感 (H5N1) 疫苗接种的成人中的安全性和免疫原性

2015-02-2311
OAAI
Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes
2011-10-06175
OA